Buckley Wealth Management, LLC Abb Vie Inc. Transaction History

Buckley Wealth Management, LLC

$319 Million
Q3 2024

A detailed history of Buckley Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Buckley Wealth Management, LLC holds 16,502 shares of ABBV stock, worth $2.97 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

16,502

Previous 16,354 0.9%

Holding current value

$2.97 Million

Previous $2.81 Million 16.15%

% of portfolio

1.02%

Previous 0.9%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$163.84 - $199.33 $24,248 - $29,500	148 Added 0.9%	16,502 $3.26 Million
Q2 2024 Jul 23, 2024	BUY	$154.79 - $180.76 $42,567 - $49,709	275 Added 1.71%	16,354 $2.81 Million
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $28,447 - $32,413	-178 Reduced 1.09%	16,079 $2.93 Million
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $6,192 - $6,973	-45 Reduced 0.28%	16,257 $2.52 Million
Q3 2023 Oct 13, 2023	BUY	$133.59 - $154.65 $25,782 - $29,847	193 Added 1.2%	16,302 $2.43 Million
Q2 2023 Jul 11, 2023	SELL	$132.51 - $164.9 $452,389 - $562,968	-3,414 Reduced 17.49%	16,109 $2.17 Million
Q1 2023 Apr 14, 2023	SELL	$144.61 - $166.54 $167,024 - $192,353	-1,155 Reduced 5.59%	19,523 $3.11 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $162,652 - $195,063	-1,176 Reduced 5.38%	20,678 $3.34 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $153,133 - $175,634	-1,141 Reduced 4.96%	21,854 $2.93 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $553,370 - $703,514	4,021 Added 21.19%	22,995 $3.52 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $73,380 - $91,045	556 Added 3.02%	18,974 $3.08 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $105,711 - $133,755	984 Added 5.64%	18,418 $2.49 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $95,121 - $107,977	894 Added 5.41%	17,434 $1.88 Million
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $29,774 - $33,170	283 Added 1.74%	16,540 $1.86 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $98,310 - $108,227	961 Added 6.28%	16,257 $1.76 Million
Q4 2020 Jan 20, 2021	BUY	$80.49 - $108.67 $71,475 - $96,498	888 Added 6.16%	15,296 $1.64 Million
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $44,157 - $51,826	514 Added 3.7%	14,408 $1.26 Million
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $52,753 - $70,591	719 Added 5.46%	13,894 $1.36 Million
Q1 2020 Apr 10, 2020	BUY	$64.5 - $97.79 $329,917 - $500,195	5,115 Added 63.46%	13,175 $1 Million
Q3 2019 Oct 11, 2019	BUY	$62.98 - $75.72 $115,001 - $138,264	1,826 Added 29.29%	8,060 $610,000
Q2 2019 Jul 19, 2019	BUY	$65.7 - $83.98 $27,594 - $35,271	420 Added 7.22%	6,234 $453,000
Q3 2018 Oct 25, 2018	SELL	$88.91 - $98.84 $8,535 - $9,488	-96 Reduced 1.62%	5,814 $550,000
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $87,355 - $103,361	-973 Reduced 14.14%	5,910 $548,000
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $26,406 - $35,361	-287 Reduced 4.0%	6,883 $651,000
Q4 2017 Feb 07, 2018	BUY	$89.56 - $98.21 $642,145 - $704,165	7,170	7,170 $693,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckley Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckley Wealth Management, LLC with notifications on news.

Account

Buckley Wealth Management, LLC Abb Vie Inc. Transaction History